Dr. Michael Linenberger is a hematologist who treats patients with blood cancers such as leukemia, lymphoma, myeloproliferative neoplasms and myelodysplastic syndromes, or blood disorders such as anemia, sickle cell disease, thrombosis and bleeding. His research focuses on apheresis, the procedure for removing specific cell types from blood. He is an expert in bone marrow and peripheral blood stem cell procurement for transplantation, collection of immune effector cells, and safety issues for patients and recipients of cell-based therapies. At Fred Hutch, he is the chief medical director of the Cell Processing Facility. At Seattle Cancer Care Alliance, Fred Hutch’s clinical care partner, he is medical director of Apheresis and Cellular Therapy and the collection center for the National Marrow Donor Program. He is actively involved in teaching at the University of Washington and Fred Hutch, where he directs the adult Hematology/Oncology Fellowship Program.